2 weeks Ago By Defense World Staff
Envestnet Asset Management Inc. lifted its stake in shares of Bath & Body Works, Inc. ( NYSE:BBWI – Free Report ) by 21.
7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 168,736 shares of the company’s stock after buying an additional 30,042 shares during the quarter. Envestnet Asset Management Inc.
owned approximately 0.08% of Bath & Body Works worth $6,542,000 at the end of the most recent reporting period. Other hedge funds have also recently added to or reduced their stakes in the company.
Bard Financial Services Inc. purchased a new stake in Bath & Body Works during the third quarter worth approximately $412,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Bath & Body Works in the 3rd quarter valued at $39,000.
Franklin Resources Inc. lifted its position in Bath & Body Works by 50.8% in the third quarter.
Franklin Resources Inc. now owns 265,221 shares of the company’s stock valued at $8,230,000 after acquiring an additional 89,350 shares during the last quarter. Principal Financial Group Inc.
grew its holdings in shares of Bath & Body Works by 328.7% during the third quarter. Principal Financial Group Inc.
now owns 1,069,941 shares of the company’s stock worth $34,153,000 after purchasing an additional 820,379 shares during the last quarter. Finally, Versant Capital Management Inc increased its position in shares of Bath & Body Works by 161.7% during the fourth quarter.
Versant Capital Management Inc now owns 2,141 shares of the company’s stock worth $83,000 after purchasing an additional 1,323 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Analysts Set New Price Targets Several analysts recently commented on BBWI shares. Raymond James reduced their price target on shares of Bath & Body Works from $46.00 to $37.
00 and set an “outperform” rating for the company in a research report on Thursday. Telsey Advisory Group reaffirmed an “outperform” rating and set a $43.00 price objective on shares of Bath & Body Works in a research note on Thursday, February 27th.
JPMorgan Chase & Co. lowered their target price on Bath & Body Works from $47.00 to $41.
00 and set an “overweight” rating on the stock in a research note on Monday, April 14th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Citigroup dropped their target price on Bath & Body Works from $48.
00 to $36.00 and set a “buy” rating on the stock in a research report on Monday, April 7th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock.
According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average target price of $43.13.
Bath & Body Works Trading Up 3.4 % Bath & Body Works stock opened at $28.42 on Monday.
The stock has a fifty day moving average price of $32.15 and a 200 day moving average price of $33.90.
Bath & Body Works, Inc. has a 52 week low of $24.96 and a 52 week high of $52.
99. The firm has a market capitalization of $6.09 billion, a P/E ratio of 6.
93, a PEG ratio of 0.92 and a beta of 1.69.
Bath & Body Works ( NYSE:BBWI – Get Free Report ) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.
04 by $0.05. The business had revenue of $2.
79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.
03% and a net margin of 12.43%. As a group, equities analysts predict that Bath & Body Works, Inc.
will post 3.3 EPS for the current year. Bath & Body Works Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th.
Investors of record on Friday, February 21st were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st.
This represents a $0.80 annualized dividend and a dividend yield of 2.81%.
Bath & Body Works’s payout ratio is 21.98%. Bath & Body Works declared that its Board of Directors has approved a share buyback program on Thursday, February 27th that authorizes the company to buyback $500.
00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.4% of its stock through open market purchases.
Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued. Bath & Body Works Profile ( Free Report ) Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Further Reading Five stocks we like better than Bath & Body Works Are Penny Stocks a Good Fit for Your Portfolio? With a 60%+ Upside, There’s Plenty to Love About Lovesac What is the Australian Securities Exchange (ASX) J.
B. Hunt Transport Overcorrects Into a Buying Opportunity 10 Best Airline Stocks to Buy AppLovin: Can Record Profits Overcome Market Skepticism? Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc.
( NYSE:BBWI – Free Report ). Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter .
.
